MLchartDataset catalogue

GTI-2040

Term · Oncology and biomedicine · MLC-T-ONC-003683

A substance being studied in the treatment of cancer. It blocks the production of a protein called ribonucleotide reductase, which helps cells make DNA. This may kill cancer cells that need ribonucleotide reductase to grow. It may also make cells more sensitive to anticancer drugs. It is a type of antisense oligonucleotide, and a type of ribonucleotide reductase inhibitor.

Table 1. Record
IdentifierMLC-T-ONC-003683
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003683",
  "term": "GTI-2040",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. It blocks the production of a protein called ribonucleotide reductase, which helps cells make DNA. This may kill cancer cells that need ribonucleotide reductase to grow. It may also make cells more sensitive to anticancer drugs. It is a type of antisense oligonucleotide, and a type of ribonucleotide reductase inhibitor.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/gti-2040/"
}

Record 8,215 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.